PRFX

PRF Technologies Ltd. NASDAQ Listed Sep 1, 2020

Healthcare ·Drug Manufacturers - Specialty & Generic ·IL · prf-tech.com

$1.90

Mkt Cap $153,011

52w Low $1.80 0.6% of range 52w High $17.95

50d MA $2.44 200d MA $4.79

P/E (TTM) -0.2x

EV/EBITDA 0.5x

P/B 0.1x

Debt/Equity 0.0x

ROE -58.8%

P/FCF -0.5x

RSI (14) —

ATR (14) —

Beta 0.71

50d MA $2.44

200d MA $4.79

Avg Volume 709.0K

PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.

SIC Code

2834

CIK (SEC)

1801834

Phone

972 3 717 7050

65 Yigal Alon Street · Tel Aviv 6745442 · IL

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Oct 2, 2025	AMC	—	-9.60	—	6.80	+1.5%	+1.5%	+0.7%	-2.2%	+8.8%	-3.4%	—
Oct 1, 2025	AMC	—	-9.60	—	6.90	+0.7%	-1.4%	+1.5%	+0.7%	-2.2%	+8.8%	—
Jun 4, 2025	AMC	—	-13.63	—	10.55	-2.8%	-6.6%	+4.6%	-4.4%	+3.9%	-2.2%	—
Apr 4, 2025	AMC	—	-83.98	—	10.45	-5.3%	-8.1%	-9.0%	+4.1%	+18.1%	-3.3%	—
Nov 19, 2024	AMC	-4.74	-15.04	-217.2%	7.00	-25.0%	-25.7%	+207.7%	-7.2%	-4.0%	-4.6%	—
Aug 15, 2024	AMC	-6.24	-9.60	-53.8%	9.09	+5.0%	+11.2%	-7.7%	-15.4%	+4.6%	-2.5%	—
May 15, 2024	AMC	-2.40	-65.27	-2619.6%	24.00	+1.4%	+0.0%	+5.8%	-8.9%	-2.7%	+0.0%	—
Feb 29, 2024	AMC	-1.49	-83.98	-5536.2%	57.00	+4.7%	+21.4%	-9.0%	-1.9%	-1.0%	+2.5%	—
Nov 15, 2023	AMC	-1.40	11.52	+922.9%	63.90	+2.8%	-4.7%	+4.9%	-5.6%	+2.5%	+4.4%	—
Aug 10, 2023	AMC	-300.00	-1220.48	-306.8%	204.00	-3.2%	-0.4%	-5.9%	-8.5%	-5.8%	-3.1%	—
May 15, 2023	AMC	-264.00	-52.79	+80.0%	180.90	+0.5%	+3.6%	-0.8%	-1.6%	+1.1%	+1.3%	—
Mar 16, 2023	AMC	-180.00	-69.59	+61.3%	150.00	+1.0%	+5.2%	+5.1%	+0.0%	-3.3%	+2.8%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Oct 24	Maxim Group	Downgrade	Buy → Hold	—	$3.67	$3.50	-4.6%	-4.6%	-8.9%	-6.0%	-6.7%	+3.6%
Jun 26	Maxim Group	Maintains	Buy → Buy	—	$13.80	$14.10	+2.2%	+2.6%	+5.5%	-3.6%	+1.5%	+0.2%

Data updated apr 26, 2026 8:37pm · Source: massive.com